Prevalence of Diabetes and Pre-diabetes in Class III and Class IV Healthy Obese Employees of KIMS University, Maharashtra
Prevalence of Diabetes and Pre-Diabetes in Healthy Obese Employees
Keywords:
Obesity, Diabetes, Pre-diabetes, Oral glucose tolerance test, Glycosylated hemoglobinAbstract
Background & objectives: Diabetes is the most common metabolic disorder and its prevalence is increasing in almost all countries. The aim of the study was to estimate the prevalence of undiagnosed diabetes and pre-diabetes in class III and class IV healthy obese employees of Krishna Institute of Medical Sciences (KIMS) University, Karad, Maharashtra. Methods: We screened 600 employees of KIMS University, out of these 105 were included in this study. We studied oral glucose tolerance test (OGGT) and glycosylated hemoglobin (HbA1c) in study group. Classification of new cases was based on the oral glucose tolerance test (OGGT). Results: The prevalence of undiagnosed diabetes among class III and class IV healthy obese employees was 3.8 %, where as pre-diabetics 7.6% making total of 11.4%. Oral glucose tolerance test (OGGT) level was significantly higher (P<0.001) in diabetics and pre-diabetics when compared to non-diabetics. Normal or low level of glycosylated hemoglobin (HbA1c) was found in diabetics and pre-diabetics. Conclusion: The findings of our study and their implication would help to design disease prevention and to reduce morbidity in healthy obese individuals. We recommend that screening for the diabetes and pre-diabetes should be employed as part of routine occupational health check-up programme and OGTT may be the gold standard test to identify undiagnosed diabetes and pre-diabetes in healthy obese individuals
References
2. Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res. 2007; 125(3): 217-230.
3. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections. Diabetes Care 1998; 21(9):1414-1431.
4. Sicree R, Shaw J, Zimmet P. Diabetes and impaired glucose tolerance. In: Gan D, editor. Diabetes Atlas. International Diabetes Federation. 3rd ed. Belgium: International Diabetes Federation; 2006 p. 15-103.
5. Gavin JR, Alberti KGMM, Davidson MB, DeFronzo RA, Drash A, Gabbe SG, et.al. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. The Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26(Suppl 1): S5-S20.
6. Oberlinner C, Neumann SM, Ott MG, Zober A. Screening for pre-diabetes and diabetes in the workplace. Occup Med (Lond). 2008; 58(1): 41-45.
7. Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, et.al. American Diabetes Association. Consensus statement. Impaired fasting glucose and Impaired glucose tolerance: implications for care. Diabetes Care 2007; 30(3):735-759.
8. American Diabetes Association. Position statement. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006; 29(Suppl 1): S43-S48.
9. World Health Organization. Report of a World Health Organization and International Diabetes Federation Meeting: Screening for type 2 diabetes. Geneva, World Health Org., 2003.
10. American Diabetes Association. Position Statement. Screening for type 2 diabetes. Diabetes Care 2004; 27(Suppl 1):S11–S14.
11. American Diabetes Association. Position Statement. The prevention or delay of type 2 diabetes. Diabetes Care 2003; 26(Suppl 1):S62–S66.
12. Twigg SM, Kamp MC, Davis TM, Neylon EK, Flack JR; Australian Diabetes Society; Australian Diabetes Educators Association. Prediabetes: a position statement from the Australian Diabetes Society and Australian Diabetes Educators Association. Med J Aust. 2007; 186(9):461-5.
13. World Health Organization: Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: Report of a WHO/IDF consultation. Geneva, World Health Org., 2006. Available from http://www.idf.org/webdat a/docs /WHO_IDF_definition_diagnosis_of diabetes.pdf (downloaded on19.12.2010).
14. World Health Organization, Western Pacific Region. The International Association for the Study of Obesity and the International Obesity Task Force. The Asia–Pacific perspective: redefining obesity and its treatment. Sydney, Australia: Health Communications Australia Pvt Limited; 2000.Available: www.diabetes.com.au /pdf/obesity_report.pdf (accessed on 19.12.2010)
15. Trinder P. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol. 1969; 22(2):158-61.
16. Trivelli LA, Ranney HM, Lai HT. Hemoglobin components in patients with diabetes mellitus. N Engl J Med.1971; 284(7):353-357.
17. King H, Rewers M. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Diabetes Reporting Group. Diabetes Care 1993; 16(1):157-177.
18. Mohan V, Shanthirani CS, Deepa R. Glucose intolerance (diabetes and IGT) in a selected South Indian population with special reference to family history, obesity and lifestyle factors-the Chennai Urban Population Study (CUPS 14). J Assoc Physicians India. 2003; 51(8):771-777.
19. Ramachandran A, Snehalatha C, Kapur A, Vijay V, Mohan V, Das AK, et al; Diabetes Epidemiology Study Group in India (DESI). Highprevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia. 2001; 44(9):1094-101.
20. Ramachandran A, Snehalatha C, Latha E, Manoharan M, Vijay V. Impacts of urbanisation on the lifestyle and on the prevalence of diabetes in native Asian Indian population. Diabetes Res Clin Pract. 1999; 44(3):207-13.
21. Bennett CM, Guo M, Dharmage SC. HbA(1c) as a screening tool for detection of type 2 diabetes: a systemic review. Diabet Med. 2007; 24(4):333-343.
22. Qvist R, Shah II, Karuthan C, Sekaran M. Use of glycated hemoglobin (HbA1C) and impaired glucose tolerance in the screening of undiagnosed diabetes in the Malaysian population. Ind J Clin Biochem 2008; 23(3):246-249.
23. Arnold JG, McGowan HJ. Delay in diagnosis of diabetes mellitus due to inaccurate use of hemoglobin A1C levels. J Am Board Fam Med. 2007; 20(1):93-96.
